Poynard T. Long term prognostic value of the FibroTest in patients with non-alcoholic-fatty-liver disease (NAFLD), compared to chronic hepatitis C (CHC), B (CHB), and alcoholic liver disease (ALD). PS-183.
Radboud start fase I/II-studie naar COVID-19-vaccin
mrt 2021 | Vaccinatie, Virale infecties